{"id":"https://openalex.org/W1982910460","doi":"https://doi.org/10.1089/rej.2010.1134","title":"Switching the Microglial Harmful Phenotype Promotes Lifelong Restoration of Subtantia Nigra Dopaminergic Neurons from Inflammatory Neurodegeneration in Aged Mice","display_name":"Switching the Microglial Harmful Phenotype Promotes Lifelong Restoration of Subtantia Nigra Dopaminergic Neurons from Inflammatory Neurodegeneration in Aged Mice","alternate_titles":[],"publication_year":2011,"publication_date":"2011-07-27","ids":{"openalex":"https://openalex.org/W1982910460","doi":"https://doi.org/10.1089/rej.2010.1134","mag":"1982910460","pmid":"https://pubmed.ncbi.nlm.nih.gov/21793734"},"language":"en","primary_location":{"id":"doi:10.1089/rej.2010.1134","doi":"https://doi.org/10.1089/rej.2010.1134","is_oa":false,"landing_page_url":"https://doi.org/10.1089/rej.2010.1134","pdf_url":null,"source":{"id":"https://openalex.org/S171625771","display_name":"Rejuvenation Research","issn_l":"1094-5458","issn":["1094-5458","1549-1684","1557-8577","1557-8984"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rejuvenation Research","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1982910460"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031496401","display_name":"Francesca L\u2019Episcopo","orcid":"https://orcid.org/0000-0003-3292-9677","observed_orcids":["https://orcid.org/0000-0003-3292-9677"]},"institutions":[{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca L'Episcopo","raw_affiliation_strings":["OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","institution_ids":[]},{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy","institution_ids":["https://openalex.org/I4210090132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075407827","display_name":"Cataldo Tirolo","orcid":"https://orcid.org/0000-0003-1747-8134","observed_orcids":["https://orcid.org/0000-0003-1747-8134"]},"institutions":[{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cataldo Tirolo","raw_affiliation_strings":["OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","institution_ids":[]},{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy","institution_ids":["https://openalex.org/I4210090132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001302471","display_name":"Nunzio Testa","orcid":"https://orcid.org/0000-0002-4024-2325","observed_orcids":["https://orcid.org/0000-0002-4024-2325"]},"institutions":[{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Nunzio Testa","raw_affiliation_strings":["OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","institution_ids":[]},{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy","institution_ids":["https://openalex.org/I4210090132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021181399","display_name":"Salvatore Caniglia","orcid":"https://orcid.org/0000-0002-9416-8458","observed_orcids":["https://orcid.org/0000-0002-9416-8458"]},"institutions":[{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Salvatore Caniglia","raw_affiliation_strings":["OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","institution_ids":[]},{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy","institution_ids":["https://openalex.org/I4210090132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013252840","display_name":"Maria C. Morale","orcid":"https://orcid.org/0000-0003-0624-7234","observed_orcids":["https://orcid.org/0000-0003-0624-7234"]},"institutions":[{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Concetta Morale","raw_affiliation_strings":["OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","institution_ids":[]},{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy","institution_ids":["https://openalex.org/I4210090132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077892371","display_name":"Francesco Impagnatiello","orcid":"https://orcid.org/0000-0003-2220-113X","observed_orcids":["https://orcid.org/0000-0003-2220-113X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Francesco Impagnatiello","raw_affiliation_strings":["Nicox Research Institute, Italy","Nicox Research Institute, Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nicox Research Institute, Italy","institution_ids":[]},{"raw_affiliation_string":"Nicox Research Institute, Milan, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5020938978","display_name":"Bianca Marchetti","orcid":"https://orcid.org/0000-0002-9287-8448","observed_orcids":["https://orcid.org/0000-0002-9287-8448"]},"institutions":[{"id":"https://openalex.org/I39063666","display_name":"University of Catania","ror":"https://ror.org/03a64bh57","country_code":"IT","type":"education","lineage":["https://openalex.org/I39063666"]},{"id":"https://openalex.org/I4210090132","display_name":"Oasi Maria SS","ror":"https://ror.org/00dqmaq38","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210090132","https://openalex.org/I4210153126"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Bianca Marchetti","raw_affiliation_strings":["Department of Clinical and Molecular Biomedicine, Italy","OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","University of Catania, Italy","Department of Clinical and Molecular Biomedicine, Pharmacology Section, Faculty of Medicine, Catania, Italy","Faculty of Pharmacy, University of Catania, Catania, Italy","OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Clinical and Molecular Biomedicine, Italy","institution_ids":[]},{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Italy","institution_ids":[]},{"raw_affiliation_string":"University of Catania, Italy","institution_ids":["https://openalex.org/I39063666"]},{"raw_affiliation_string":"Department of Clinical and Molecular Biomedicine, Pharmacology Section, Faculty of Medicine, Catania, Italy","institution_ids":["https://openalex.org/I39063666"]},{"raw_affiliation_string":"Faculty of Pharmacy, University of Catania, Catania, Italy","institution_ids":["https://openalex.org/I39063666"]},{"raw_affiliation_string":"OASI Institute for Research and Care on Mental Retardation and Brain Aging, Neuropharmacology Section, Troina, Italy","institution_ids":["https://openalex.org/I4210090132"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5020938978"],"corresponding_institution_ids":["https://openalex.org/I39063666","https://openalex.org/I4210090132"],"apc_list":null,"apc_paid":null,"fwci":1.8283,"has_fulltext":false,"cited_by_count":42,"citation_normalized_percentile":{"value":0.82009132,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"14","issue":"4","first_page":"411","last_page":"424"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.8062000274658203,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11266","display_name":"Neuroinflammation and Neurodegeneration Mechanisms","score":0.8062000274658203,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.19020000100135803,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.9409999847412109},{"id":"https://openalex.org/keywords/substantia-nigra-pars-compacta","display_name":"substantia nigra pars compacta","score":0.9240000247955322},{"id":"https://openalex.org/keywords/dopaminergic-neuron-degeneration","display_name":"dopaminergic neuron loss","score":0.9010000228881836},{"id":"https://openalex.org/keywords/microglial-activation","display_name":"microglial activation","score":0.9269999861717224},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.8700000047683716},{"id":"https://openalex.org/keywords/aging","display_name":"aging","score":0.5799999833106995},{"id":"https://openalex.org/keywords/flurbiprofen","display_name":"flurbiprofen","score":0.7360000014305115},{"id":"https://openalex.org/keywords/nitric-oxide-donors","display_name":"nitric oxide donors","score":0.8820000290870667},{"id":"https://openalex.org/keywords/nonsteroidal-anti-inflammatory-drugs","display_name":"nonsteroidal anti-inflammatory drugs","score":0.9539999961853027},{"id":"https://openalex.org/keywords/lipopolysaccharide","display_name":"lipopolysaccharide","score":0.9639999866485596},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9150000214576721},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.6800000071525574},{"id":"https://openalex.org/keywords/immunomodulation","display_name":"immunomodulation","score":0.7850000262260437}],"concepts":[{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.8355936408042908},{"id":"https://openalex.org/C2776773494","wikidata":"https://www.wikidata.org/wiki/Q3366041","display_name":"Pars compacta","level":5,"score":0.8147773742675781},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.7178003191947937},{"id":"https://openalex.org/C2780938664","wikidata":"https://www.wikidata.org/wiki/Q753278","display_name":"Substantia nigra","level":4,"score":0.6886459589004517},{"id":"https://openalex.org/C2779830541","wikidata":"https://www.wikidata.org/wiki/Q1622829","display_name":"Microglia","level":3,"score":0.5860245823860168},{"id":"https://openalex.org/C87753298","wikidata":"https://www.wikidata.org/wiki/Q17157137","display_name":"Neuroinflammation","level":3,"score":0.5057525634765625},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.5042062997817993},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.5020432472229004},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4852764308452606},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4757140278816223},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.47194164991378784},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.35189810395240784},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3155767321586609},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3135940432548523},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2985115647315979},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.2281259298324585},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.1319849193096161}],"mesh":[{"descriptor_ui":"D000375","descriptor_name":"Aging","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000375","descriptor_name":"Aging","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005480","descriptor_name":"Flurbiprofen","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D005480","descriptor_name":"Flurbiprofen","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D008070","descriptor_name":"Lipopolysaccharides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009410","descriptor_name":"Nerve Degeneration","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D009410","descriptor_name":"Nerve Degeneration","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D009416","descriptor_name":"Nerve Regeneration","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D010641","descriptor_name":"Phenotype","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D012333","descriptor_name":"RNA, Messenger","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013378","descriptor_name":"Substantia Nigra","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D014446","descriptor_name":"Tyrosine 3-Monooxygenase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015538","descriptor_name":"Nitrosation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017628","descriptor_name":"Microglia","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017628","descriptor_name":"Microglia","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D018384","descriptor_name":"Oxidative Stress","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059290","descriptor_name":"Dopaminergic Neurons","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D059290","descriptor_name":"Dopaminergic Neurons","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D060888","descriptor_name":"Real-Time Polymerase Chain Reaction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/rej.2010.1134","doi":"https://doi.org/10.1089/rej.2010.1134","is_oa":false,"landing_page_url":"https://doi.org/10.1089/rej.2010.1134","pdf_url":null,"source":{"id":"https://openalex.org/S171625771","display_name":"Rejuvenation Research","issn_l":"1094-5458","issn":["1094-5458","1549-1684","1557-8577","1557-8984"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rejuvenation Research","raw_type":"journal-article"},{"id":"pmid:21793734","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21793734","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rejuvenation research","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320321781","display_name":"Ministero della Salute","ror":"https://ror.org/00789fa95"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":77,"referenced_works":["https://openalex.org/W1480874656","https://openalex.org/W1530199299","https://openalex.org/W1558100964","https://openalex.org/W1580441010","https://openalex.org/W1587360940","https://openalex.org/W1629697287","https://openalex.org/W1668344921","https://openalex.org/W1771976412","https://openalex.org/W1933195856","https://openalex.org/W1974924674","https://openalex.org/W1975774284","https://openalex.org/W1981018409","https://openalex.org/W1981310043","https://openalex.org/W1990000696","https://openalex.org/W1990872391","https://openalex.org/W1992911806","https://openalex.org/W1997962428","https://openalex.org/W1999627663","https://openalex.org/W1999922500","https://openalex.org/W2003321649","https://openalex.org/W2003473535","https://openalex.org/W2004205580","https://openalex.org/W2010414623","https://openalex.org/W2011441557","https://openalex.org/W2014184499","https://openalex.org/W2017364016","https://openalex.org/W2020656090","https://openalex.org/W2021467687","https://openalex.org/W2022325044","https://openalex.org/W2023164204","https://openalex.org/W2033558692","https://openalex.org/W2039190334","https://openalex.org/W2039357975","https://openalex.org/W2043122628","https://openalex.org/W2043676089","https://openalex.org/W2053051103","https://openalex.org/W2055750901","https://openalex.org/W2056546282","https://openalex.org/W2057913943","https://openalex.org/W2058594344","https://openalex.org/W2064487089","https://openalex.org/W2068312274","https://openalex.org/W2072210142","https://openalex.org/W2079768378","https://openalex.org/W2080300101","https://openalex.org/W2082510957","https://openalex.org/W2084100208","https://openalex.org/W2095376584","https://openalex.org/W2098097762","https://openalex.org/W2098898203","https://openalex.org/W2100657323","https://openalex.org/W2109759840","https://openalex.org/W2111464898","https://openalex.org/W2112815582","https://openalex.org/W2116819366","https://openalex.org/W2120331429","https://openalex.org/W2120412340","https://openalex.org/W2120934545","https://openalex.org/W2125809720","https://openalex.org/W2127563454","https://openalex.org/W2131607023","https://openalex.org/W2131884118","https://openalex.org/W2136004258","https://openalex.org/W2143500251","https://openalex.org/W2145903555","https://openalex.org/W2146008698","https://openalex.org/W2149298826","https://openalex.org/W2151651399","https://openalex.org/W2154653323","https://openalex.org/W2155790751","https://openalex.org/W2158211941","https://openalex.org/W2159822434","https://openalex.org/W2165738847","https://openalex.org/W2168221521","https://openalex.org/W2471449461","https://openalex.org/W2606869650","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W4210325802","https://openalex.org/W2746380062","https://openalex.org/W2135011318","https://openalex.org/W2017850876","https://openalex.org/W1990000696","https://openalex.org/W1587360940","https://openalex.org/W1532481675","https://openalex.org/W2093192158","https://openalex.org/W2067476740"],"abstract_inverted_index":{"Aging":[0],"represents":[1],"a":[2,15,41,77,114,133,140,164,169,210,243],"major":[3],"risk":[4],"factor":[5,43],"for":[6,219,247],"the":[7,21,29,38,61,67,89,100,103,120,180,189],"development":[8],"and":[9,47,95,143,148],"progression":[10,62],"of":[11,24,63,102,122,136,168,175,179,192,213],"Parkinson":[12],"disease":[13],"(PD),":[14],"chronic":[16],"degenerative":[17],"disorder":[18],"characterized":[19],"by":[20,130],"selective":[22],"loss":[23,212],"dopaminergic":[25],"(DAergic)":[26],"neurons":[27,215],"in":[28,44,72,80,116,195,202],"subtantia":[30],"nigra":[31],"pars":[32],"compacta":[33],"(SNpc).":[34],"Emerging":[35],"evidence":[36],"highlights":[37],"glia":[39,241],"as":[40,242],"pivotal":[42],"PD":[45],"etiology,":[46],"epidemiological":[48],"studies":[49],"indicate":[50],"that":[51,66,87,138],"certain":[52],"nonsteroidal":[53,127],"antiinflammatory":[54,128],"drugs":[55],"(NSAIDs)":[56],"may":[57,75],"prevent":[58],"or":[59,154,227],"delay":[60],"PD.":[64],"Given":[65],"exaggerated":[68],"inflammatory":[69,107],"response":[70,92,196],"observed":[71],"old":[73],"age":[74],"play":[76],"critical":[78],"role":[79],"exacerbating":[81],"DAergic":[82,214,238,248],"vulnerability,":[83],"we":[84,112,118],"hypothesize":[85],"here":[86],"switching":[88],"harmful":[90],"glial":[91,184],"to":[93,105,163,197,199,235],"inflammation":[94],"oxidative":[96],"stress":[97],"might":[98],"increase":[99,191],"ability":[101],"SN":[104],"resist":[106],"attacks.":[108],"To":[109],"this":[110],"end,":[111],"developed":[113],"treatment":[115],"which":[117],"combined":[119],"effects":[121],"nitric":[123],"oxide":[124],"(NO)":[125],"with":[126,152,216,231],"activity":[129],"using":[131],"HCT1026,":[132],"NO-donating":[134],"derivative":[135],"flurbiprofen":[137],"has":[139],"safe":[141],"profile":[142],"additional":[144],"immunomodulatory":[145],"properties.":[146],"Young":[147],"aged":[149,206,228],"mice":[150,226,229],"fed":[151,230],"control":[153],"HCT1026":[155,186,232],"(30":[156],"mg":[157,173],"kg(-1)":[158],"day(-1))":[159],"diet":[160],"were":[161,233],"exposed":[162],"single":[165],"systemic":[166,236],"injection":[167],"subtoxic":[170],"dose":[171],"(0.2":[172],"kg(-1))":[174],"lipopolysaccharide":[176],"(LPS),":[177],"one":[178],"most":[181],"extensively":[182],"used":[183],"activators.":[185],"efficiently":[187],"reversed":[188],"age-dependent":[190],"microglial":[193],"activation":[194],"LPS":[198,208],"levels":[200],"measured":[201],"younger":[203,225],"mice.":[204],"In":[205],"mice,":[207],"induced":[209],"progressive":[211],"no":[217],"recovery":[218],"their":[220],"entire":[221],"life":[222],"span,":[223],"whereas":[224],"resistant":[234],"LPS-induced":[237],"neurodegeneration,":[239],"underscoring":[240],"key":[244],"pharmacological":[245],"target":[246],"neuroprotection.":[249]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1982910460","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":7},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
